BSE Live
Nov 21, 16:01Prev. Close
6463.80
Open Price
6467.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 21, 16:08Prev. Close
6462.50
Open Price
6462.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
6373.00 (474)
| Balance Sheet of Divis Laboratories (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 26.55 | 26.55 | 26.55 | 26.55 | 26.52 | |
| Total Share Capital | 26.55 | 26.55 | 26.55 | 26.55 | 26.52 | |
| Reserves and Surplus | 3,535.41 | 3,007.87 | 2,526.73 | 2,148.25 | 1,801.53 | |
| Total Reserves and Surplus | 3,535.41 | 3,007.87 | 2,526.73 | 2,148.25 | 1,801.53 | |
| Total Shareholders Funds | 3,561.96 | 3,034.42 | 2,553.28 | 2,174.80 | 1,828.05 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 1.05 | 1.55 | 2.10 | 2.56 | 4.92 | |
| Deferred Tax Liabilities [Net] | 132.45 | 121.67 | 86.55 | 67.29 | 54.91 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 6.25 | 9.62 | |
| Long Term Provisions | 6.99 | 3.18 | 2.39 | 1.65 | 2.82 | |
| Total Non-Current Liabilities | 140.49 | 126.40 | 91.04 | 77.75 | 72.27 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 25.07 | 16.32 | 30.51 | 50.20 | 13.62 | |
| Trade Payables | 224.38 | 148.69 | 158.31 | 157.31 | 121.24 | |
| Other Current Liabilities | 202.73 | 146.55 | 129.35 | 134.70 | 105.04 | |
| Short Term Provisions | 320.14 | 311.58 | 233.42 | 208.21 | 167.92 | |
| Total Current Liabilities | 772.32 | 623.14 | 551.59 | 550.42 | 407.82 | |
| Total Capital And Liabilities | 4,474.77 | 3,783.96 | 3,195.91 | 2,802.97 | 2,308.13 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 1,304.77 | 1,221.60 | 908.50 | 738.19 | 589.73 | |
| Intangible Assets | 3.95 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 218.18 | 144.48 | 303.41 | 181.99 | 104.34 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 1,526.91 | 1,366.09 | 1,211.91 | 920.18 | 694.06 | |
| Non-Current Investments | 2.82 | 2.82 | 2.82 | 2.82 | 2.82 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 149.07 | 119.02 | 107.27 | 124.69 | 73.72 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 3.93 | 3.69 | |
| Total Non-Current Assets | 1,678.79 | 1,487.93 | 1,322.00 | 1,051.62 | 774.29 | |
| CURRENT ASSETS | ||||||
| Current Investments | 733.00 | 501.88 | 407.81 | 477.04 | 525.64 | |
| Inventories | 1,114.90 | 893.27 | 805.95 | 650.97 | 543.07 | |
| Trade Receivables | 823.03 | 791.64 | 558.90 | 533.97 | 392.78 | |
| Cash And Cash Equivalents | 56.66 | 35.77 | 34.68 | 21.82 | 12.80 | |
| Short Term Loans And Advances | 59.16 | 67.38 | 59.89 | 64.03 | 58.12 | |
| OtherCurrentAssets | 9.23 | 6.11 | 6.68 | 3.52 | 1.44 | |
| Total Current Assets | 2,795.98 | 2,296.04 | 1,873.91 | 1,751.35 | 1,533.84 | |
| Total Assets | 4,474.77 | 3,783.96 | 3,195.91 | 2,802.97 | 2,308.13 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 231.13 | 220.87 | 221.73 | 299.15 | 295.68 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 714.67 | 484.26 | 447.99 | 348.64 | 236.99 | |
| Stores, Spares And Loose Tools | 2.69 | 2.27 | 3.15 | 2.90 | 1.31 | |
| Trade/Other Goods | 2.69 | 2.27 | 3.15 | 2.90 | 1.31 | |
| Capital Goods | 23.76 | 19.44 | 16.24 | 11.55 | 12.24 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 14.56 | 11.35 | 11.41 | 7.96 | 5.24 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | 0.00 | 0.00 | 0.07 | 0.05 | 0.03 | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 2,624.38 | 2,257.64 | 1,860.16 | 1,606.88 | 1,181.19 | |
| Other Earnings | 7.33 | 4.21 | 18.77 | 8.21 | 2.38 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 13.12 | 13.12 | 13.12 | 13.12 | 13.12 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 2.83 | 2.83 | 2.83 | 2.83 | 2.83 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | 733.00 | 501.88 | 407.81 | 477.04 | 525.73 |
20.11.2025
Accumulate Divis Laboratories; target of Rs 6795: Deven Choksey
14.11.2025
Divis Labs Consolidated September 2025 Net Sales at Rs 2,715.00 crore, up 16.12% Y-o-Y
12.11.2025
Neutral Divis Laboratories; target of Rs 6925: Motilal Oswal
12.11.2025
Divis Labs Standalone September 2025 Net Sales at Rs 2,660.00 crore, up 15.55% Y-o-Y
24.05.2024
Divi's Labs Q4 preview: Revenue, net profit to grow on normalised base, better product mix
04.11.2023
Divi's Labs Q2 Preview: Earnings likely to improve sequentially on better margins, product mix
14.08.2023
Divi's Labs Q1 Preview: Base effect to pressure earnings, brokerages predict sequential recovery
19.05.2023
Divi's Labs Preview: Unfavourable base, elevated input costs to turn Q4 a sour pill